| Cytokeratin 16 expression is particularly pronounced in conditions such as wound healing, psoriasis and also in some carcinomas such as basal cell carcinoma. |
|
| Catalog # | C9097-15O |
| Applications | Suitable for use in Immunohistochemistry. Other applications not tested. |
| Recommended Dilution | Immunohistochemistry (Frozen and Paraffin): 1:20-1:40 Paraffin sections require antigen retrieval using heat treatment methods prior to staining. Sodium Citrate buffer pH 6.0 is recommended for this purpose. |
| Optimal dilutions to be determined by the researcher. |
| Hybridoma | Spleen cells from immunized mice were fused with cells of the mouse SP2/0-Ag14 myeloma cell line. |
| Positive Control | Non-melanocytic skin cancer, basal cell carcinoma |
| Recommended Secondary Reagents | I1904-65W: IgG, F(ab’)2 (HRP) Pab RbxMo |
| I1904-66C: IgG, F(ab’)2, X-Adsorbed (HRP) Pab RbxMo |
| Recommended Negative Controls | I1904-79G: IgG1, Mouse, Negative Control |
| Storage and Stability | May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. |
| CAS Number | n/a |
| Clone Type | Monoclonal |
| Isotype | IgG1 |
| Clone No | 6A401 |
| Host | Mouse |
| Source | Human |
| Concentration | Not Determined |
| Form | Supplied as a liquid, 0.09% sodium azide. |
| Purity | Tissue Culture Supernatant |
| Immunogen | Synthetic peptide derived from the C-terminus of human cytokeratin 16. |
| Specificity | Recognizes human cytokeratin 16, expressed in areas where there is high turnover of keratinocytes. |
|
|
| Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
